Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.01 USD
Change Today 0.00 / 0.00%
Volume 0.0
ROIX On Other Exchanges
As of 4:30 PM 04/13/15 All times are local (Market data is delayed by at least 15 minutes).

response oncology inc (ROIX) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/13/15 - $0.01
52 Week Low
12/23/14 - $0.0001
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for RESPONSE ONCOLOGY INC (ROIX)

Related News

No related news articles were found.

response oncology inc (ROIX) Related Businessweek News

No Related Businessweek News Found

response oncology inc (ROIX) Details

Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers.

10 Employees
Last Reported Date: 06/13/02

response oncology inc (ROIX) Top Compensated Officers

Chairman of the Board, Chief Executive Office...
Total Annual Compensation: --
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: --
Vice Chairman of the Board
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROIX:US $0.01 USD 0.00

ROIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ROIX.
View Industry Companies

Industry Analysis


Industry Average

Valuation ROIX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESPONSE ONCOLOGY INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at